Intrapleural low-dose silver nitrate elicits more pleural inflammation and less systemic inflammation than low dose talc

被引:18
作者
Marchi, E
Vargas, FS
Teixeira, LR
Acencio, MMP
Antonangelo, L
Light, RW
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Div Pulm,Pleura Lab, Sao Paulo, Brazil
[2] Vanderbilt Univ, Nashville, TN USA
[3] St Thomas Hosp, Nashville, TN USA
基金
巴西圣保罗研究基金会;
关键词
inflammation; pleura; pleural effusion; pleurodesis; silver nitrate; systemic inflammatory response; talc;
D O I
10.1378/chest.128.3.1798
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Several systemic effects have been described after tale pleurodesis. The aim of this study was to assess the systemic response induced by low, nonpleurodesis-inducing doses of tale and silver nitrate in an experimental model in rabbits. Design: Groups of six rabbits were injected intrapleurally with tale, 100 mg/kg or 400 mg/kg, and silver nitrate, 0.1% or 0.5%. After 6, 24, or 48 h, samples of blood and pleural fluid were collected and assayed for leukocytes, percentage of neutrophils, lactate dehydrogenase, interleukin-8, and vascular endothelial growth factor (VEGF) levels. Preinjection blood samples were used as normal blood controls. Measurements and results: Silver nitrate 0.1% induced a more intense pleural inflammation than that produced by tale 100 mg/kg. In contrast, tale 100 mg/kg induced a more pronounced acute systemic response with higher values of WBCs and neutrophils, whereas silver nitrate 0.1% produced no significant increases in leukocytes or neutrophils. The serum interleukin-8 and VEGF levels, increased in all groups, and decreased with time only in the silver nitrate 0.1% group. The highest serum VEGF levels were observed in the tale 160 mg/kg group. Conclusions: In conclusion, 0.1% silver nitrate produced an intense pleural inflammatory response with a less evident systemic response in comparison to 0.5% silver nitrate and tale 100 mg/kg or 400 mg/kg.
引用
收藏
页码:1798 / 1804
页数:7
相关论文
共 44 条
[1]  
AGRENIUS V, 1991, EUR RESPIR J, V4, P1135
[2]  
ANDERSEN I, 1959, Acta Chir Scand, V118, P105
[3]   INTRACAVITARY BLEOMYCIN FOR THE CONTROL OF MALIGNANT EFFUSIONS [J].
BITRAN, JD ;
BROWN, C ;
DESSER, RK ;
KOZLOFF, MF ;
SHAPIRO, C ;
BILLINGS, AA .
JOURNAL OF SURGICAL ONCOLOGY, 1981, 16 (03) :273-277
[4]   RECURRENT AND CHRONIC SPONTANEOUS PNEUMOTHORAX [J].
BROCK, RC .
THORAX, 1948, 3 (02) :88-110
[5]   Respiratory failure due to insufflated talc [J].
Campos, JRM ;
Werebe, EC ;
Vargas, FS ;
Jatene, FB ;
Light, RW .
LANCET, 1997, 349 (9047) :251-252
[6]   Thoracoscopy talc poudrage - A 15-year experience [J].
de Campos, JRM ;
Vargas, FS ;
Werebe, ED ;
Cardoso, P ;
Teixeira, LR ;
Jatene, FB ;
Light, RW .
CHEST, 2001, 119 (03) :801-806
[7]   Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis [J].
Ferrer, J ;
Montes, JF ;
Villarino, MA ;
Light, RW ;
García-Valero, J .
CHEST, 2002, 122 (03) :1018-1027
[8]   Talc preparations used for pleurodesis vary markedly from one preparation to another [J].
Ferrer, J ;
Villarino, MA ;
Tura, JM ;
Traveria, A ;
Light, RW .
CHEST, 2001, 119 (06) :1901-1905
[9]   Distribution of calibrated talc after intrapleural administration - An experimental study in rats [J].
Fraticelli, A ;
Robaglia-Schlupp, A ;
Riera, H ;
Monjanel-Mouterde, S ;
Cau, P ;
Astoul, P .
CHEST, 2002, 122 (05) :1737-1741
[10]  
GRAVELYN TR, 1987, CANCER, V59, P1973, DOI 10.1002/1097-0142(19870601)59:11<1973::AID-CNCR2820591124>3.0.CO